The pathogenesis of atherosclerosis: a perspective for the 1990s
R. Ross

Single intraluminal delivery of antisense cdc2 kinase and proliferating cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia
R. Morishita and others

Systemic delivery of recombinant proteins by genetically modified myoblasts
E. Barr and J.M. Leiden

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
M. Simons and others

Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium
M.H. Soonpaa and others

Site-specific gene expression in vivo by direct gene transfer into the arterial wall
E.G. Nabel and others

High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range
R.D. Cone and R.C. Mulligan

Gene therapy for vascular smooth muscle cell proliferation after arterial injury
T. Ohno and others

Genetic engineering of vein grafts resistant to atherosclerosis
M.J. Mann and others

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene
H.E. von der Leyen and others